{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:23:53Z","timestamp":1790277833626,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jns.2016.02.031","type":"journal-article","created":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T17:17:59Z","timestamp":1455643079000},"page":"116-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["HLA-DRB1*14 and DQB1*05 are associated with Japanese anti-MuSK antibody-positive myasthenia gravis patients"],"prefix":"10.1016","volume":"363","author":[{"given":"Tetsuya","family":"Kanai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyuki","family":"Uzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tateo","family":"Sakamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumasa","family":"Yoshiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Himuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2016.02.031_bb0005","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/cen3.12091","article-title":"Clinical features and treatment status of adult myasthenia gravis in Japan","volume":"5","author":"Murai","year":"2014","journal-title":"Clinical and Experimental Neuroimmunology"},{"key":"10.1016\/j.jns.2016.02.031_bb0010","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ana.23691","article-title":"Risk for myasthenia gravis maps to a (151) Pro\u2192Ala change in TNIP1 and to human leukocyte antigen-B*08","volume":"72","author":"Gregersen","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2016.02.031_bb0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1034\/j.1399-0039.2003.00062.x","article-title":"New allele frequenct data base: www.allelefrequencies.net","volume":"61","author":"Middleton","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jns.2016.02.031_bb0020","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.57.9.1555","article-title":"Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies","volume":"57","author":"Giraud","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.02.031_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-510X(01)00573-1","article-title":"Polymorphic markers in MHC class II\/III region: a study on Italian patients with myasthenia gravis","volume":"190","author":"Franciotta","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2016.02.031_bb0030","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jocn.2011.05.002","article-title":"Association between HLA-DRB1 and myasthenia gravis in a northern Han Chinese population","volume":"18","author":"Xie","year":"2011","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2016.02.031_bb0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1744-313X.2010.00979.x","article-title":"Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States","volume":"38","author":"Deitiker","year":"2011","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.jns.2016.02.031_bb0040","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.humimm.2006.02.039","article-title":"HLA-DQ polymorphism in Turkish patients with myasthenia gravis","volume":"67","author":"Saruhan-Direskeneli","year":"2006","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jns.2016.02.031_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036603","article-title":"Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population","volume":"7","author":"Maniaol","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2016.02.031_bb0050","article-title":"Association of HLA-DQB1*05:02 and DRB1*16 alleles with late-onset, nonthymomatous, AChR-Ab-positive myasthenia gravis","volume":"541760","author":"Testi","year":"2012","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.jns.2016.02.031_bb0055","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/01.wnl.0000218159.79769.5c","article-title":"Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5","volume":"66","author":"Niks","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.02.031_bb0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1212\/01.wnl.0000339103.08830.86","article-title":"HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5","volume":"72","author":"Bartoccioni","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.02.031_bb0065","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.humimm.2013.08.271","article-title":"Association of HLA-DRB1*14, -DRB1*16 and -DQB1*05 with MuSK-myasthenia gravis in patients from Turkey","volume":"74","author":"Alahgholi-Hajibehzad","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jns.2016.02.031_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.12525","article-title":"High frequency of DQB1*05 and absolute absence of DRB1*13 in muscle-specific tyrosine kinase positive myasthenia gravis","volume":"22","author":"Nikolic","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2016.02.031_bb0075","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jneuroim.2010.10.023","article-title":"Clinical and immunological differences between early and late-onset myasthenia gravis in Japan","volume":"230","author":"Suzuki","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2016.02.031_bb0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America (MGFA)","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.02.031_bb0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaut.2013.12.007","article-title":"T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients","volume":"52","author":"Marino","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jns.2016.02.031_bb0090","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clim.2003.10.004","article-title":"A variant of childhood-onset myasthenia gravis: HLA typing and clinical charasteristics in Japan","volume":"110","author":"Shinomiya","year":"2004","journal-title":"Clin. Immunol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1630096X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1630096X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T00:54:04Z","timestamp":1536972844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X1630096X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":18,"alternative-id":["S0022510X1630096X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2016.02.031","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-DRB1*14 and DQB1*05 are associated with Japanese anti-MuSK antibody-positive myasthenia gravis patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2016.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}